Table 2 Treatment responses
From: Clinical significance of the cachexia index in patients with small cell lung cancer
Treatment response | LD | ED | ||||
|---|---|---|---|---|---|---|
High-CXI group (n = 83) | Low-CXI group (n = 24) | p | High-CXI group (n = 123) | Low-CXI group (n = 37) | p | |
Complete response (CR) | 30 (36.1%) | 1 (4.2%) | 0.004 | 2 (1.6%) | 0 (0.0%) | <  0.001 |
Partial response (PR) | 49 (59.0%) | 18 (75.0%) | Â | 103 (83.7%) | 20 (54.1%) | Â |
Stable disease or progressive disease | 1 (1.2%) | 2 (8.3%) | Â | 15 (12.2%) | 10 (27.0%) | Â |
Not available | 3 (3.6%) | 3 (12.5%) | Â | 3 (2.4%) | 7 (18.9%) | Â |
Objective response rate (CR + PR) | 79 (95.2%) | 19 (79.2%) | 0.026 | 105 (85.4%) | 20 (54.1%) | <  0.001 |